MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2016 International Congress

    A case of thalamic malignant glioma formation in a patient with STN-DBS for Parkinson’s disease

    A. Tomskiy, A. Gamaleya, N. Gubareva, Y. Latyshev, G. Kobyakov, L. Shishkina, I. Pronin (Moscow, Russia)

    Objective: We present a case of development of malignant glioma (glioblastoma multiforme) in the area adjacent to electrostimulation zone in a patient with chronic STN-DBS,…
  • 2016 International Congress

    Effects of deep brain stimulation in the nucleus entopeduncularis on neuronal network activity after apomorphine-induced deficient sensorimotor gating in a rat model

    K. Schwabe, L. Götz, J.K. Krauss, M. Alam (Hannover, Germany)

    Objective: Deficient sensorimotor gating induced by dopamine receptor agonists is used as an endophenotype for certain neuropsychiatric disorders, such as Tourette´s syndrome (TS), schizophrenia, and…
  • 2016 International Congress

    Can deep brain stimulation implantation cause multiple system atrophy? A retrospective review of MSA patients

    E.A. Coon, B.T. Klassen, J.E. Ahlskog, P.A. Low, W. Singer (Rochester, MN, USA)

    Objective: To evaluate whether implantation of deep brain stimulation (DBS) could lead to multiple system atrophy (MSA). Background: Recent studies regarding the transmissibility of alpha-synuclein…
  • 2016 International Congress

    Interest in genetic testing in Parkinson’s disease patients with deep brain stimulation

    G. Pal, E. Tam, R. Bhavsar, C. Timms, L. Verhagen, D. Hall, K. Marder (Chicago, IL, USA)

    Objective: To determine interest in genetic testing in Parkinson's disease (PD) patients with deep brain stimulation (DBS). Background: Approximately 27% of early-onset PD patients with…
  • 2016 International Congress

    Quantitative assessment of DBS-induced gait disorder in patients with essential tremor

    D. Kroneberg, T. Schmitz-Hübsch, A. Gropp, G.H. Schneider, A.A. Kühn (Berlin, Germany)

    Objective: To investigate changes in gait coordination quantitatively in patients with essential tremor (ET) under chronic bilateral high-frequency stimulation of the nucleus ventralis intermedius (VIM).…
  • 2016 International Congress

    Intraoperative localization of beta band and high-frequency oscillations within the subthalamic nucleus

    B.C.M. van Wijk, A. Pogosyan, T. Foltynie, M.I. Hariz, P. Limousin, L. Zrinzo, P. Brown, V. Litvak (London, United Kingdom)

    Objective: To investigate whether beta band activity (13-30Hz) and high-frequency oscillations (150-400Hz) arise from the same spatial location within the subthalamic nucleus (STN) of Parkinson's…
  • 2016 International Congress

    Combined pallidal and thalamic stimulation for multifocal primary dystonia with prominent writers’ cramp

    A. Wloch, M. Abdallat, G. Lütjens, C. Schrader, J.K. Krauss (Hannover, Germany)

    Objective: When a patient presents with both writer's cramp and other dystonic symptoms, it is unclear which target should be chosen. Multifocal DBS is a…
  • 2016 International Congress

    A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study

    D. van Poppelen, R.M.A. de Bie, J.M. Dijk (Amsterdam, Netherlands)

    Objective: To compare costs and effectiveness of the therapies DBS and CLI in advanced PD. Background: The therapies deep brain stimulation (DBS) and continuous intrajejunale…
  • 2016 International Congress

    Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome

    A. Medina, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate distance between the physiologically defined subthalamic nucleus (STN) target and final lead placement, and its influence on the clinical outcome at 6…
  • 2016 International Congress

    Is inter-limb coupling modified by subthalamic deep brain stimulation and dopaminergic medication in Parkinson’s disease?

    C. Duval, J.F. Daneault, A.F. Sadikot (Montréal, QC, Canada)

    Objective: We characterized different aspects of bimanual coordination in patients with PD, including inter-limb coupling, and then determined whether they were altered by therapeutic modulation…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 169
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29077 (not found)
  • #29056 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28189 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley